Degrasyn WP1130 (also known as WP-1130) is a chemical compound that is used in scientific research as a potent and selective inhibitor of deubiquitinases (DUBs). This inhibition has potential applications in treating certain medical conditions related to abnormal protein turnover, such as cancer.
Chemical name: The chemical name of Degrasyn WP1130 is 3-(3-tert-Butyl-1H-pyrazol-5-yl)-N-(4-chlorophenyl)sulfonamide.
Molecular formula: The molecular formula of Degrasyn WP1130 is C16H18ClN3O2S.
Formula weight: The molecular weight of Degrasyn WP1130 is 347.85 g/mol.
CAS No: The CAS number of Degrasyn WP1130 is 856243-80-6.
Top ten keywords from Google and Synonyms:
Synonyms: • WP-1130 • NSC 727447 • 3-(3-tert-Butyl-1H-pyrazol-5-yl)-N-(4-chlorophenyl)sulfonamide • DUB inhibitor WP1130
Health benefits of this product: Degrasyn WP1130 inhibits the activity of deubiquitinases (DUBs), which play a role in various cellular processes like protein degradation, signal transduction, cell cycle regulation, and apoptosis. By inhibiting DUBs, Degrasyn WP1130 can potentially affect these processes, leading to changes in cell behavior, including cell cycle arrest or apoptosis. This inhibition has potential applications in treating certain medical conditions related to abnormal protein turnover, such as cancer.
Potential effects: Degrasyn WP1130 inhibits the activity of deubiquitinases (DUBs), which play a role in various cellular processes like protein degradation, signal transduction, cell cycle regulation, and apoptosis. By inhibiting DUBs, Degrasyn WP1130 can potentially affect these processes, leading to changes in cell behavior, including cell cycle arrest or apoptosis. This inhibition has potential applications in treating certain medical conditions related to abnormal protein turnover, such as cancer.
Product mechanism: Degrasyn WP1130 inhibits the activity of deubiquitinases (DUBs) by binding to the active site of the enzyme. DUBs are involved in various cellular processes, including protein degradation, signal transduction, cell cycle regulation, and apoptosis. By inhibiting DUBs, Degrasyn WP1130 can block these processes and potentially reduce abnormal protein turnover.
Safety: Degrasyn WP1130 is mainly used in scientific research and has not been approved for human use. Its safety in humans is not well established, and there may be potential side effects associated with its use. Individuals should seek advice from a healthcare professional before using Degrasyn WP1130.
Side effects: The potential side effects of Degrasyn WP1130 are not well-established as it is primarily used in scientific research. However, there may be potential risks associated with its use, including toxicity and effects on normal protein turnover.
Dosing information: Degrasyn WP1130 is mainly used in scientific research and dosing information is determined based on the specific experiment being performed. Individuals should consult with a qualified scientist or healthcare professional for guidance on appropriate dosing.
Conclusion: Degrasyn WP1130 is a chemical compound that is commonly used in scientific research as a potent and selective inhibitor of deubiquitinases (DUBs). The inhibition of DUBs has potential applications in treating certain medical conditions related to abnormal protein turnover, such as cancer. Although mainly used in scientific research, potential side effects and safety concerns should be taken into consideration if considering its use. Further studies are needed to determine the safety and efficacy of Degrasyn WP1130 for human use
